Cargando…

The effect of intra-articular botulinum toxin A on substance P, prostaglandin E(2), and tumor necrosis factor alpha in the canine osteoarthritic joint

BACKGROUND: Recently, intra-articular botulinum toxin A (IA BoNT A) has been shown to reduce joint pain in osteoarthritic dogs. Similar results have been reported in human patients with arthritis. However, the mechanism of the antinociceptive action of IA BoNT A is currently not known. The aim of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Heikkilä, Helka M., Hielm-Björkman, Anna K., Innes, John F., Laitinen-Vapaavuori, Outi M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359943/
https://www.ncbi.nlm.nih.gov/pubmed/28327134
http://dx.doi.org/10.1186/s12917-017-0990-y
_version_ 1782516490359013376
author Heikkilä, Helka M.
Hielm-Björkman, Anna K.
Innes, John F.
Laitinen-Vapaavuori, Outi M.
author_facet Heikkilä, Helka M.
Hielm-Björkman, Anna K.
Innes, John F.
Laitinen-Vapaavuori, Outi M.
author_sort Heikkilä, Helka M.
collection PubMed
description BACKGROUND: Recently, intra-articular botulinum toxin A (IA BoNT A) has been shown to reduce joint pain in osteoarthritic dogs. Similar results have been reported in human patients with arthritis. However, the mechanism of the antinociceptive action of IA BoNT A is currently not known. The aim of this study was to explore this mechanism of action by investigating the effect of IA BoNT A on synovial fluid (SF) and serum substance P (SP), prostaglandin E(2) (PGE(2)), and tumor necrosis factor alpha (TNF-α) in osteoarthritic dogs. Additionally, the aim was to compare SF SP and PGE(2) between osteoarthritic and non-osteoarthritic joints, and investigate associations between SP, PGE(2), osteoarthritic pain, and the signalment of dogs. Thirty-five dogs with chronic naturally occurring osteoarthritis and 13 non-osteoarthritic control dogs were included in the study. Osteoarthritic dogs received either IA BoNT A (n = 19) or IA placebo (n = 16). Serum and SF samples were collected and osteoarthritic pain was evaluated before (baseline) and 2 and 8 weeks after treatment. Osteoarthritic pain was assessed with force platform, Helsinki Chronic Pain Index, and joint palpation. Synovial fluid samples were obtained from control dogs after euthanasia. The change from baseline in SP and PGE(2) concentration was compared between the IA BoNT A and placebo groups. The synovial fluid SP and PGE(2) concentration was compared between osteoarthritic and control joints. Associations between SP, PGE(2), osteoarthritic pain, and the signalment of dogs were evaluated. RESULTS: There was no significant change from baseline in SP or PGE(2) after IA BoNT A. Synovial fluid PGE(2) was significantly higher in osteoarthritic compared to control joints. Synovial fluid PGE(2) correlated with osteoarthritic pain. No associations were found between SP or PGE(2) and the signalment of dogs. The concentration of TNF-α remained under the detection limit of the assay in all samples. CONCLUSIONS: The results suggest that the antinociceptive effect of IA BoNT A in the joint might not be related to the inhibition of SP nor PGE(2). Synovial fluid PGE(2), but not SP, could be a marker for chronic osteoarthritis and pain in dogs.
format Online
Article
Text
id pubmed-5359943
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53599432017-03-22 The effect of intra-articular botulinum toxin A on substance P, prostaglandin E(2), and tumor necrosis factor alpha in the canine osteoarthritic joint Heikkilä, Helka M. Hielm-Björkman, Anna K. Innes, John F. Laitinen-Vapaavuori, Outi M. BMC Vet Res Research Article BACKGROUND: Recently, intra-articular botulinum toxin A (IA BoNT A) has been shown to reduce joint pain in osteoarthritic dogs. Similar results have been reported in human patients with arthritis. However, the mechanism of the antinociceptive action of IA BoNT A is currently not known. The aim of this study was to explore this mechanism of action by investigating the effect of IA BoNT A on synovial fluid (SF) and serum substance P (SP), prostaglandin E(2) (PGE(2)), and tumor necrosis factor alpha (TNF-α) in osteoarthritic dogs. Additionally, the aim was to compare SF SP and PGE(2) between osteoarthritic and non-osteoarthritic joints, and investigate associations between SP, PGE(2), osteoarthritic pain, and the signalment of dogs. Thirty-five dogs with chronic naturally occurring osteoarthritis and 13 non-osteoarthritic control dogs were included in the study. Osteoarthritic dogs received either IA BoNT A (n = 19) or IA placebo (n = 16). Serum and SF samples were collected and osteoarthritic pain was evaluated before (baseline) and 2 and 8 weeks after treatment. Osteoarthritic pain was assessed with force platform, Helsinki Chronic Pain Index, and joint palpation. Synovial fluid samples were obtained from control dogs after euthanasia. The change from baseline in SP and PGE(2) concentration was compared between the IA BoNT A and placebo groups. The synovial fluid SP and PGE(2) concentration was compared between osteoarthritic and control joints. Associations between SP, PGE(2), osteoarthritic pain, and the signalment of dogs were evaluated. RESULTS: There was no significant change from baseline in SP or PGE(2) after IA BoNT A. Synovial fluid PGE(2) was significantly higher in osteoarthritic compared to control joints. Synovial fluid PGE(2) correlated with osteoarthritic pain. No associations were found between SP or PGE(2) and the signalment of dogs. The concentration of TNF-α remained under the detection limit of the assay in all samples. CONCLUSIONS: The results suggest that the antinociceptive effect of IA BoNT A in the joint might not be related to the inhibition of SP nor PGE(2). Synovial fluid PGE(2), but not SP, could be a marker for chronic osteoarthritis and pain in dogs. BioMed Central 2017-03-21 /pmc/articles/PMC5359943/ /pubmed/28327134 http://dx.doi.org/10.1186/s12917-017-0990-y Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Heikkilä, Helka M.
Hielm-Björkman, Anna K.
Innes, John F.
Laitinen-Vapaavuori, Outi M.
The effect of intra-articular botulinum toxin A on substance P, prostaglandin E(2), and tumor necrosis factor alpha in the canine osteoarthritic joint
title The effect of intra-articular botulinum toxin A on substance P, prostaglandin E(2), and tumor necrosis factor alpha in the canine osteoarthritic joint
title_full The effect of intra-articular botulinum toxin A on substance P, prostaglandin E(2), and tumor necrosis factor alpha in the canine osteoarthritic joint
title_fullStr The effect of intra-articular botulinum toxin A on substance P, prostaglandin E(2), and tumor necrosis factor alpha in the canine osteoarthritic joint
title_full_unstemmed The effect of intra-articular botulinum toxin A on substance P, prostaglandin E(2), and tumor necrosis factor alpha in the canine osteoarthritic joint
title_short The effect of intra-articular botulinum toxin A on substance P, prostaglandin E(2), and tumor necrosis factor alpha in the canine osteoarthritic joint
title_sort effect of intra-articular botulinum toxin a on substance p, prostaglandin e(2), and tumor necrosis factor alpha in the canine osteoarthritic joint
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359943/
https://www.ncbi.nlm.nih.gov/pubmed/28327134
http://dx.doi.org/10.1186/s12917-017-0990-y
work_keys_str_mv AT heikkilahelkam theeffectofintraarticularbotulinumtoxinaonsubstancepprostaglandine2andtumornecrosisfactoralphainthecanineosteoarthriticjoint
AT hielmbjorkmanannak theeffectofintraarticularbotulinumtoxinaonsubstancepprostaglandine2andtumornecrosisfactoralphainthecanineosteoarthriticjoint
AT innesjohnf theeffectofintraarticularbotulinumtoxinaonsubstancepprostaglandine2andtumornecrosisfactoralphainthecanineosteoarthriticjoint
AT laitinenvapaavuorioutim theeffectofintraarticularbotulinumtoxinaonsubstancepprostaglandine2andtumornecrosisfactoralphainthecanineosteoarthriticjoint
AT heikkilahelkam effectofintraarticularbotulinumtoxinaonsubstancepprostaglandine2andtumornecrosisfactoralphainthecanineosteoarthriticjoint
AT hielmbjorkmanannak effectofintraarticularbotulinumtoxinaonsubstancepprostaglandine2andtumornecrosisfactoralphainthecanineosteoarthriticjoint
AT innesjohnf effectofintraarticularbotulinumtoxinaonsubstancepprostaglandine2andtumornecrosisfactoralphainthecanineosteoarthriticjoint
AT laitinenvapaavuorioutim effectofintraarticularbotulinumtoxinaonsubstancepprostaglandine2andtumornecrosisfactoralphainthecanineosteoarthriticjoint